Jordan Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jordan Healthcare Press.

Press releases published on October 6, 2026

3 hours ago

Oak Hill Bio Appoints Joerg Hipp, PhD as Chief Translational Science Officer

Indeterminate GlobeNewswire

3 hours ago

vTv Therapeutics to Host Virtual KOL Event on Hypoglycemia in Type 1 Diabetes and the Cadisegliatin Phase 3 Program on October 20, 2026

Indeterminate GlobeNewswire

3 hours ago

Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise

Indeterminate GlobeNewswire

3 hours ago

LB Pharmaceuticals to Host In-Person and Virtual R&D Day on October 27, 2026: Advancing LB‑102 with a Focus on Schizophrenia Treatment

Indeterminate GlobeNewswire

3 hours ago

Collegium Launches "Start Talking ADHD" with Practical Support to Help Families Navigate Care, School and Everyday Life

Indeterminate GlobeNewswire

3 hours ago

Fort Wayne Medical Oncology and Hematology Launches New Radiation Oncology Division: Fort Wayne Radiation Oncology

Indeterminate GlobeNewswire

3 hours ago

Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI® (berdazimer) Topical Gel, 10.3%

Indeterminate GlobeNewswire

3 hours ago

Hydrafacial Introduces HydraClear™ Treatment Booster to Clarify Blemish-Prone Skin

Indeterminate GlobeNewswire

3 hours ago

Stryker announces leadership succession

Indeterminate GlobeNewswire

3 hours ago

Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company

Indeterminate GlobeNewswire

3 hours ago

PDS Biotech to Host Key Opinion Leader Event on PDS0301 for the Treatment of Advanced Colorectal Cancer with Liver Metastases

Indeterminate GlobeNewswire

3 hours ago

Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026

Indeterminate GlobeNewswire

3 hours ago

YD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor Assessment

Indeterminate GlobeNewswire

3 hours ago

Akebia Therapeutics Announces Late-Breaking VOICE Trial Presentation and Posters on Akebia’s Rare Kidney Pipeline at ASN Kidney Week 2026

Indeterminate GlobeNewswire

3 hours ago

Madrigal Announces Publication in the Journal of Hepatology Demonstrating Consistent Rezdiffra Efficacy Across Common MASH Genetic Risk Variants

Indeterminate GlobeNewswire

3 hours ago

ArriVent Announces Program Update from the Phase 3 FURVENT Trial of Firmonertinib in First-Line EGFR Exon 20 Insertion Mutant NSCLC

Indeterminate GlobeNewswire

4 hours ago

Porch Light Health Awarded $6.6 Million Through Colorado Rural Health Transformation Program

Indeterminate GlobeNewswire

4 hours ago

TSC Life Receives FDA Clearance for Mistral-Air® MA1400 Forced Air Warming System

Indeterminate GlobeNewswire

4 hours ago

BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting

Indeterminate GlobeNewswire

4 hours ago

SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Indeterminate GlobeNewswire